Conference Coverage

Declining androgen levels correlated with increased frailty

Publish date: March 27, 2018

 

REPORTING FROM ENDO 2018

Dr. Wu is on the advisory board of Bayer-Schering, Eli Lilly, and Besins Healthcare. Dr. Wu is a research supporter or consultant for Repros Therapeutics, Merck Serono, and Mereo Biopharma. Investigators reported no additional relevant financial disclosures.

SOURCE: Wu F C et al. ENDO 2018, Abstract OR15-1.

Pages

Recommended Reading

Early births stress dads too
MDedge Internal Medicine
Ciprofloxacin cured gyrA wild-type Neisseria gonorrhoeae infections
MDedge Internal Medicine
From cells to socioeconomics, meth worsens HIV outcomes
MDedge Internal Medicine
Still too early to determine impact of 1-year deferral for MSM blood donors
MDedge Internal Medicine
Abstract: Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
MDedge Internal Medicine
Free testosterone linked to frailty in older men
MDedge Internal Medicine
Without reliability, testosterone testing may fall short
MDedge Internal Medicine
VIDEO: Researchers closing in on the elusive ‘male pill’
MDedge Internal Medicine
MDedge Daily News: Stem cells may reverse premature menopause
MDedge Internal Medicine
Sexual harassment, violence is our problem, too
MDedge Internal Medicine